Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Ulcerative colitis: prevention of relapse.

Naganuma M, Sakuraba A, Hibi T.

Expert Rev Gastroenterol Hepatol. 2013 May;7(4):341-51. doi: 10.1586/egh.13.18. Review.

PMID:
23639092
2.

Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.

Bressler B, Marshall JK, Bernstein CN, Bitton A, Jones J, Leontiadis GI, Panaccione R, Steinhart AH, Tse F, Feagan B; Toronto Ulcerative Colitis Consensus Group.

Gastroenterology. 2015 May;148(5):1035-1058.e3. doi: 10.1053/j.gastro.2015.03.001. Epub 2015 Mar 4. Review.

PMID:
25747596
3.

Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.

Yamamoto S, Nakase H, Matsuura M, Masuda S, Inui K, Chiba T.

J Clin Gastroenterol. 2011 Jul;45(6):526-30. doi: 10.1097/MCG.0b013e318209cdc4.

4.

Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.

Lichtenstein GR, Gordon GL, Zakko S, Murthy U, Sedghi S, Pruitt R, Barrett AC, Bortey E, Paterson C, Forbes WP.

Dig Dis Sci. 2016 Jan;61(1):221-9. doi: 10.1007/s10620-015-3866-7. Epub 2015 Nov 12.

5.

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.

Carbonnel F, Colombel JF, Filippi J, Katsanos KH, Peyrin-Biroulet L, Allez M, Nachury M, Novacek G, Danese S, Abitbol V, Bossa F, Moreau J, Bommelaer G, Bourreille A, Fumery M, Roblin X, Reinisch W, Bouhnik Y, Brixi H, Seksik P, Malamut G, Färkkilä M, Coulibaly B, Dewit O, Louis E, Deplanque D, Michetti P, Sarter H, Laharie D; European Crohn's and Colitis Organisation; Groupe d'Étude Thérapeutique des Affections Inflammatoires Digestives.

Gastroenterology. 2016 Feb;150(2):380-8.e4. doi: 10.1053/j.gastro.2015.10.050. Epub 2015 Nov 26.

PMID:
26632520
6.

Overview of biological therapy in ulcerative colitis: current and future directions.

Furfaro F, Bezzio C, Ardizzone S, Massari A, de Franchis R, Maconi G.

J Gastrointestin Liver Dis. 2015 Jun;24(2):203-13. doi: 10.15403/jgld.2014.1121.242.bezz. Review.

7.

Efficacy and safety of infliximab in treating patients with ulcerative colitis: experiences from a single medical center in southern China.

Zhou YL, Xie S, Wang P, Zhang T, Lin MY, Tan JS, Zhi FC, Jiang B, Chen Y.

J Dig Dis. 2014 Sep;15(9):483-90. doi: 10.1111/1751-2980.12161.

PMID:
24828856
8.

Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.

Yamamoto S, Nakase H, Matsuura M, Honzawa Y, Masuda S, Inui K, Chiba T.

J Gastroenterol Hepatol. 2010 May;25(5):886-91. doi: 10.1111/j.1440-1746.2009.06206.x.

PMID:
20546441
9.

A review of infliximab use in ulcerative colitis.

Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.

Clin Ther. 2008 Feb;30(2):223-30. doi: 10.1016/j.clinthera.2008.02.014. Review.

PMID:
18343261
10.

Review article: the management of steroid dependency in ulcerative colitis.

Bianchi Porro G, Cassinotti A, Ferrara E, Maconi G, Ardizzone S.

Aliment Pharmacol Ther. 2007 Sep 15;26(6):779-94. Review.

11.

Management of acute severe ulcerative colitis.

Doherty GA, Cheifetz AS.

Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):395-405. doi: 10.1586/egh.09.24. Review.

PMID:
19673626
12.

Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

Marshall JK, Thabane M, Steinhart AH, Newman JR, Anand A, Irvine EJ.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004118. doi: 10.1002/14651858.CD004118.pub2. Review.

PMID:
23152224
13.

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.

Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi Porro G.

Gut. 2006 Jan;55(1):47-53. Epub 2005 Jun 21.

14.

Probiotics for maintaining remission of ulcerative colitis in adults.

Do VT, Baird BG, Kockler DR.

Ann Pharmacother. 2010 Mar;44(3):565-71. doi: 10.1345/aph.1M498. Epub 2010 Feb 2. Review.

PMID:
20124461
15.

Medical management of ulcerative colitis.

Thuraisingam A, Leiper K.

Hosp Med. 2003 Dec;64(12):703-7. Review.

PMID:
14702780
16.

Mild-to-moderate ulcerative colitis: your role in patient compliance and health care costs.

Tindall WN, Boltri JM, Wilhelm SM.

J Manag Care Pharm. 2007 Sep;13(7 Suppl A):S2-12; quiz S13-4.

PMID:
17874873
17.
18.

Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.

Regueiro M, Loftus EV Jr, Steinhart AH, Cohen RD.

Inflamm Bowel Dis. 2006 Oct;12(10):979-94.

PMID:
17012969
19.

Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials.

Shen J, Zuo ZX, Mao AP.

Inflamm Bowel Dis. 2014 Jan;20(1):21-35. doi: 10.1097/01.MIB.0000437495.30052.be. Erratum in: Inflamm Bowel Dis. 2014 Dec;20(12):2526-8.

PMID:
24280877
20.

Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.

Nakano R, Iwakiri R, Ikeda Y, Kishi T, Tsuruoka N, Shimoda R, Sakata Y, Yamaguchi K, Fujimoto K.

J Gastroenterol Hepatol. 2013 Feb;28(2):303-8. doi: 10.1111/jgh.12049.

PMID:
23339387

Supplemental Content

Support Center